Palmitoylethanolamide (PEA) in the treatment of restless legs syndrome: Rationale and case report

Neurological Sciences 2026

View at publisher
Authors: Jean‐Marc Bugnicourt
DOI: 10.1007/s10072-025-08677-8
Cited by: 0
References: 13

Fields of Study & Subjects

Restless Legs Syndrome Research Parkinson's Disease Mechanisms and Treatments Sleep and related disorders

Publication details

Journal / source
Neurological Sciences
Volume
47
Issue
1
Pages
121–121
Publication date
1 January 2026
Language
EN